yes Bedger... good points.. people on here talking down the stock seem to forget about COVID ... Dental product has been ready to go for a while but covid has delayed their plans and still is doing that somewhat... not an excuse but just reality... without covid sales would have been larger .. and result in improved cash flow .. how much can't say but .. as the year progresses more should come out on this... and Remplir has been approved in Oz and being used here now in workers comp cases etc.. in Oz.. before reimbursement approval so ... things should start moving shall we say ..
I too am frustrated by the pace but thats just how it is... their product suite are truly global and worth rude amounts of money ... as well as providing substantial benefits to patients... investing is a journey .. zen like you might think but patience will be rewarded... my thoughts anyway ...
grasshopper ..
Ann: Final Data Readout for Orthocells Nerve Reconstruction Study, page-59
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add OCC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
68.5¢ |
Change
0.030(4.58%) |
Mkt cap ! $163.7M | |||
| Open | High | Low | Value | Volume |
| 67.5¢ | 69.5¢ | 67.0¢ | $539.8K | 794.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 1393 | 68.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 68.5¢ | 15395 | 2 |
View Market Depth
| Last trade - 16.10pm 12/11/2024 (20 minute delay) ? |
| OCC (ASX) Chart |